Uterine fibroids and fertility: a modern view of the problem. A literature review

Abstract

The review was made based on https://cyberleninka.ru/, PubMed, MedArt and https://rucml.ru/. Uterine fibroid is one of the most common noninflammatory diseases of female reproductive system of reproductive age. Estrogens and progesterone are tightly connected with various growth factors such as transforming growth factor beta, insulinlike growth factor, endothelial growth factor etc. Dysfunction of sex steroids, alteration of myometrium vascularization and proinflammatory changes of endometrium, associated with leiomyoma can prevent from adequate preparation of endometrium to implantation. The situation is often complicated by combination of leiomyoma and adenomyosis. Pregnancy in women with leiomyoma is associated with increased risk of miscarriage, preeclampsia and placental insufficiency. Isthmic localization of uterine fibroid is considered to be the most unfavorable as it increases the risk of cervical insufficiency. Thus, uterine fibroid is a serious reproductive problem associated with fertility reduction and other problems with childbearing.

Keywords

uterine fibroids / fertility / gestation

References

[1] Levakov СA, Budanov PV, Zairatyants OV, et al. A personalized approach to managing patients with uterine fibroids. Obstetrics and Gynecology. 2019;(12):174–182. (In Russ.). DOI: 10.18565/aig.2019.12:174-182

[2] Леваков С.А., Буданов П.В., Зайратьянц О.В. и др. Персонифицированный подход к ведению пациенток с миомой матки // Акушерство и гинекология. 2019. № 12. С. 174–182. DOI: 10.18565/aig.2019.12:174-182

[3] Struble J, Reid S, Bedaiwy MA. Adenomyosis: A clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23(2):164–185. DOI: 10.1016/j.jmig.2015.09.018

[4] Struble J., Reid S., Bedaiwy M.A. Adenomyosis: A clinical review of a challenging gynecologic condition // J. Minim. Invasive Gynecol. 2016. Vol. 23. No. 2. P. 164–185. DOI: 10.1016/j.jmig.2015.09.018

[5] Feofilova MA, Tomareva EI, Evdokimova DV. Etiology and pathogenesis of uterine myoma, its relationship with health and reproductive function of women. Journal of New Medical Technologies. 2017;24(4):249–260. (In Russ.). DOI: 10.12737/article_5a38ffb036e579.1142186

[6] Феофилова М.А., Томарева Е.И., Евдокимова Д.В. Этиология и патогенез миомы матки, ее взаимосвязь с состоянием здоровья и репродуктивной функцией женщин // Вестник новых медицинских технологий. 2017. Т. 24. № 4. С. 249–260. DOI: 10.12737/article_5a38ffb036e579.1142186

[7] Owen C, Armstrong AY. Clinical management of leiomyoma. Obstet Gynecol Clin North Am. 2015;42(1):67–85. DOI: 10.1016/j.ogc.2014.09.009

[8] Owen C., Armstrong A.Y. Clinical management of leiomyoma // Obstet. Gynecol. Clin. North. Am. 2015. Vol. 42. No. 1. P. 67–85. DOI: 10.1016/j.ogc.2014.09.009

[9] Orazov MR, Radzinsky VE, Khamoshina MB, Toktar LR. Pharmacological management of uterine leiomyoma. Obstetrics and gynecology: News. Opinions. Training. 2018;(3(21):53–62. (In Russ.). DOI: 10.24411/2303-9698-2018-13006

[10] Оразов М.Р., Радзинский В.Е., Хамошина М.Б., Токтар Л.Р. Фармакологический менеджмент лейомиомы матки // Акушерство и гинекология: новости, мнения, обучение. 2018. № 3 (21). С. 53–62. DOI: 10.24411/2303-9698-2018-13006

[11] Khashukoeva AZ, Khlynova SA, Ilyina IYu, Kerchelaeva SA. Estrogen-dependent conditions of the female reproductive system: possibilities of nonhormonal therapy using indole-3-carbinol. Obstetrics and Gynecology. 2020;(5):65–69. (In Russ.). DOI: 10.18565/aig.2020.5.65-69

[12] Хашукоева А.З., Хлынова С.А., Ильина И.Ю., Керчелаева С.А. Эстрогензависимые состояния женской репродуктивной системы: возможности негормональной терапии с применением индол-3-карбинола // Акушерство и гинекология. 2020. № 5. С. 65–69. DOI: 10.18565/aig.2020.5.65-69

[13] Bulun SE, Moravek MB, Yin P, et al. Uterine leiomyoma stem cells: Linking progesterone to growth. Semin Reprod Med. 2015;33(5):357–365. DOI: 10.1055/s-0035-1558451

[14] Bulun S.E., Moravek M.B., Yin P. et al. Uterine leiomyoma stem cells: Linking progesterone to growth // Semin. Reprod. Med. 2015. Vol. 33. No. 5. P. 357–365. DOI: 10.1055/s-0035-1558451

[15] Chabbert-Buffet N, Esber N, Bouchard P. Fibroid growth and medical options for treatment. Fertil Steril. 2014;102(3):630–639. DOI: 10.1016/j.fertnstert.2014.07.1238

[16] Chabbert-Buffet N., Esber N., Bouchard P. Fibroid growth and medical options for treatment // Fertil. Steril. 2014. Vol. 102. No. 3. P. 630–639. DOI: 10.1016/j.fertnstert.2014.07.1238

[17] Savitskiy GA, Savitskiy AG. Chto takoe mioma matki? Saint Petersburg: JeLBI-SPb; 2016. (In Russ.)

[18] Савицкий Г.А., Савицкий А.Г. Что такое миома матки? СПб.: ЭЛБИ-СПб, 2016.

[19] Mehine M, Kaasinen E, Heinonen HR, et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci USA. 2016;113(5):1315–1320. DOI: 10.1073/pnas.1518752113

[20] Mehine M., Kaasinen E., Heinonen H.R. et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers // Proc. Natl. Acad. Sci. USA. 2016. Vol. 113. No. 5. P. 1315–1320. DOI: 10.1073/pnas.1518752113

[21] Islam MS, Protic O, Stortoni P, et al. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. Fertil Steril. 2013;100(1):178–193. DOI: 10.1016/j.fertnstert.2013.03.007

[22] Islam M.S., Protic O., Stortoni P. et al. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma // Fertil. Steril. 2013. Vol. 100. No. 1. P. 178–193. DOI: 10.1016/j.fertnstert.2013.03.007

[23] Äyräväinen A, Pasanen A, Ahvenainen T, et al. Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy. Hum Reprod. 2020;35(10):2237–2244. DOI: 10.1093/humrep/deaa187

[24] Äyräväinen A., Pasanen A., Ahvenainen T. et al. Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy // Hum. Reprod. 2020. Vol. 35. No. 10. P. 2237–2244. DOI: 10.1093/humrep/deaa187

[25] Badmaeva SZ, Tschay VB, Grigoryan ES, Polstynaya GN. Uterine fibroids: modern aspects of etiology and pathogenesis. Mother and Baby in Kuzbass. 2019;1(76):4–9. (In Russ.)

[26] Бадмаева С.Ж., Цхай В.Б., Григорян Э.С., Полстяная Г.Н. Миома матки: современные аспекты этиологии и патогенеза // Мать и дитя в Кузбассе. 2019. № 1 (76). С. 4–9.

[27] Chandran S, Cairns MT, O’Brien M, et al. Effects of combined progesterone and 17β-estradiol treatment on the transcriptome of cultured human myometrial smooth muscle cells. Physiol Genomics. 2016;48(1):50–61. DOI: 10.1152/physiolgenomics.00021.2015

[28] Chandran S., Cairns M.T., O’Brien M. et al. Effects of combined progesterone and 17β-estradiol treatment on the transcriptome of cultured human myometrial smooth muscle cells // Physiol. Genomics. 2016. Vol. 48. No. 1. P. 50–61. DOI: 10.1152/physiolgenomics.00021.2015

[29] Radzinskiy VE, Fuks AM. Ginekologiya. Moscow: GEOTAR-Media, 2016.

[30] Радзинский В.Е., Фукс А.М. Гинекология. М.: ГЭОТАР-Медиа, 2016.

[31] Pestrikova TY, Yurasova EA, Yurasov IV, Chirkov AV. Rational choice of tactics in patients with uterine fibroids. Gynecology. 2017;19(5):15–19. (In Russ.)

[32] Пестрикова Т.Ю., Юрасов Е.А., Юрасов И.В., Чирков А.В. Рациональный выбор тактики ведения пациенток с миомой матки // Гинекология. 2017. Т. 19. № 5. С. 15–19. DOI: 10.26442/2079-5696_19.5.15-19

[33] Mishieva NG, Nazarenko TA. Otsenka ovarial'nogo rezerva u zhenshchin reproduktivnogo vozrasta i ego znachenie v prognozirovanii uspekha lecheniya besplodiya. Problemy reproduktsii. 2008;(4):62–65. (In Russ.)

[34] Мишиева Н.Г., Назаренко Т.А. Оценка овариального резерва у женщин репродуктивного возраста и его значение в прогнозировании успеха лечения бесплодия // Проблемы репродукции. 2008. № 4. С. 62–65.

[35] Antropova EYu. Determination value of ovarian reserve in patients with uterine fibroids after uterine artery embolization. Russian Journal of Woman and Child Health. 2019;2(1):51–54. (In Russ.). DOI: 10.32364/2618-8430-2019-2-1-51-54

[36] Антропова Е.Ю. Значение определения овариального резерва у пациенток с миомой матки после эмболизации маточных артерий // РМЖ. Мать и дитя. 2019. Т. 2. № 1. С. 51–54. DOI: 10.32364/2618-8430-2019-2-1-51-54

[37] Gemzell-Danielsson K, Meurice ME. Selective progesterone receptor modulators for contraception with added health benefits. In: Berga SL, Genazzani AR, Naftolin F, Petraglia F, editors. Menstrual Cycle Related Disorders. Vol. 7: Frontiers in Gynecological Endocrinology. Boston: Springer; 2019: 217–223. DOI: 10.1007/978-3-030-14358-9_16

[38] Gemzell-Danielsson K., Meurice M.E. Selective progesterone receptor modulators for contraception with added health benefits // Berga S.L., Genazzani A.R., Naftolin F., Petraglia F., editors. Menstrual cycle related disorders. Vol. 7: Frontiers in Gynecological Endocrinology. Boston: Springer, 2019. P. 217–223. DOI: 10.1007/978-3-030-14358-9_16

[39] Sant’Anna GDS, Brum IS, Branchini G, et al. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells. Gynecol Endocrinol. 2017;33(8):629–633. DOI: 10.1080/09513590.2017.1301924

[40] Sant’Anna G.D.S., Brum I.S., Branchini G. et al. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells // Gynecol. Endocrinol. 2017. Vol. 33. No. 8. P. 629–633. DOI: 10.1080/09513590.2017.1301924

[41] Taits AN, Ruhljada NN, Matukhin VI, et al. Contemporary concepts of uterine fibroids’ pathogenesis. Pediatrician. 2019;10(1):91–99. (In Russ.). DOI: 10.17816/PED10191-9

[42] Тайц А.Н., Рухляда Н.Н., Матухин В.И. и др. Современные представления о патогенезе миомы матки // Педиатр. 2019. № 1. С. 89–97. DOI: 10.17816/PED10191-99

[43] Bezhenar VF, Komlichenko EV, Yarmolinskaya MI, et al. Innovative approaches to reproductive function recovery in patients with uterine myoma. Obstetrics and Gynegology. 2016;(1):80–87. (In Russ.). DOI: 10.18565/aig.2016.1.80-87

[44] Беженарь В.Ф., Комличенко Э.В., Ярмолинская М.И. и др. Инновационные подходы к восстановлению репродуктивной функции у больных с миомой матки // Акушество и гинекология. 2016. № 1. С. 80–87. DOI: 10/18565/aig2016.1.80-85

[45] Chabbert-Buffet N, Esber N, Bouchard P. Fibroid growth and medical options for treatment. Fertil Steril. 2014;102(3):630–639. DOI: 10.1016/j.fertnstert.2014.07.1238

[46] Chabbert-Buffet N., Esber N., Bouchard P. Fibroid growth and medical options for treatment // Fertil. Steril. 2014. Vol. 102. No. 3. P. 630–639. DOI: 10.1016/j.fertnstert.2014.07.1238

[47] Sidorova IS, Unanyan AL, Ageev MB, et al. Current status of the pathogenesis, clinical features, diagnosis, and treatment. Akusherstvo, Ginekologiya i Reproduktsiya. 2012;66(4):622–628. (In Russ.)

[48] Сидорова И.С., Унанян А.Л., Агеев М.Б. и др. Современное состояние вопроса о патогенезе, клинике, диагностике и лечении миомы матки у женщин репродуктивного возраста // Акушерство, гинекология и репродукция. 2012. Т. 66. № 4. С. 622–628.

[49] Safarova SM. Morphological characteristics of uterine fibroids among women of reproductive age. Journal of obstetrics and women’s diseases. 2017;66(1):27–31. (In Russ.). DOI: 10.17816/JOWD66127-31

[50] Сафарова С.М. Морфологическая характеристика миомы матки среди женщин репродуктивного возраста // Журнал акушерства и женских болезней. 2017. Т. 66. № 1. C. 27–31. DOI: 10.17816/JOWD66127-31

[51] Doroha O, Iarotskyi M, Iarotska I, et al. Uterine fibroids impact on fertility and pregnancy outcome. EUREKA: Health Sciences. 2020;(2):52–58. (In Russ.). DOI: 10.21303/2504-5679.2020.001205

[52] Doroha O., Iarotskyi M., Iarotska I. et al. Uterine fibroids impact on fertility and pregnancy outcome // EUREKA: Health Sciences. 2020. № 2. P. 52–58. DOI: 10.21303/2504-5679.2020.001205

[53] Ciavattini A, Di Giuseppe J, Stortoni P, et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int. 2013;2013:173184. DOI: 10.1155/2013/173184

[54] Ciavattini A., Di Giuseppe J., Stortoni P. et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction // Obstet. Gynecol. Int. 2013. Vol. 2013. P. 173184. DOI: 10.1155/2013/173184

[55] Yoshida S, Ohara N, Xu Q, et al. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin Reprod Med. 2010;28(3):260–273. DOI: 10.1055/s-0030-1251483

[56] Yoshida S., Ohara N., Xu Q. et al. Cell-type specific actions of progesteron receptor modulators in the regulation of uterine leiomyoma growth // Semin. Reprod. Med. 2010. Vol. 28. № 3. Р. 260–273. DOI: 10.1055/s-0030-1251483

[57] Ciarmela P, Islam MS, Reis FM, et al. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update. 2011;17(6):772–790. DOI: 10.1093/humupd/dmr031

[58] Ciarmela P., Islam M.S., Reis F.M. et al. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications // Hum. Reprod. Update. 2011. Vol. 17. № 6. Р. 772–790. DOI: 10.1093/humupd/dmr031

[59] Malyshkina AI, Voronin DN, Antsiferova YuS, et al. Impact of therapy with a selective progesterone receptor modulator on the synthesis of factors that regulate apoptosis and proteolysis in the myomatous nodules of patients with large leiomyoma. Obstetrics and Gynegology. 2017;(2):64–70. DOI: 10.18565/aig.2017.2.64-70

[60] Малышкина А.И., Воронин Д.Н., Анциферова Ю.С. и др. Влияние терапии селективным модулятором прогестероновых рецепторов на синтез факторов, регулирующих апоптоз и протеолиз, в миоматозных узлах пациенток с лейомиомой больших размеров // Акушерство и гинекология. 2017. № 2. С. 64–70. DOI: 10.18565/aig.2017.2.64-70

[61] Reznik MV, Tarasenkova VA, Sobakina DA, Linde VA. Adenomyosis and uterine fibroids in terms of comorbidity. The Journal of scientific articles “Health and Education Millennium”. 2019;21( 2):43–47. DOI: 10.26787/nydha-2226-7425-2019-21-2-43-47

[62] Резник М.В., Тарасенкова В.А., Собакина Д.А., Линде В.А. Аденомиоз и миома матки с точки зрения коморбидности // Здоровье и образование в XXI веке. 2019. Т. 21. № 2. С. 43–47. DOI: 10.26787/nydha-2226-7425-2019-21-2-43-47

[63] Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592–601. DOI: 10.1016/j.rbmo.2017.06.016

[64] Vannuccini S., Tosti C., Carmona F. et al. Pathogenesis of adenomyosis: an update on molecular mechanisms // Reprod. Biomed. Online. 2017. Vol. 35. No. 5. P. 592–601. DOI: 10.1016/j.rbmo.2017.06.016

[65] Guseynova ZS. Narusheniya reproduktivnoy funktsii pri dobrokachestvennykh patologiyakh matki. Aktual’nі problemi suchasnoї medicini: Vіsnik ukraїns’koї medichnoї stomatologіchnoї akademії. 2018;18(3):307–313. (In Russ.)

[66] Гусейнова З.С. Нарушения репродуктивной функции при доброкачественных патологиях матки // Актуальні проблеми сучасної медицини: Вісник української медичної стоматологічної академії. 2018. Т. 18. № 3. (63). С. 307–313.

[67] Devesa-Peiro A, Sebastian-Leon P, Garcia-Garcia F, et al. Uterine disorders affecting female fertility: what are the molecular functions altered in endometrium? Fertil Steril. 2020;113(6):1261–1274. DOI: 10.1016/j.fertnstert.2020.01.025

[68] Devesa-Peiro A., Sebastian-Leon P., Garcia-Garcia F. et al. Uterine disorders affecting female fertility: what are the molecular functions altered in endometrium? // Fertil. Steril. 2020. Vol. 113. No. 6. P. 1261–1274. DOI: 10.1016/j.fertnstert.2020.01.025

[69] Gladchuk IZ, Rozhkovskaja NN, Garbuzenko ND, Stamova NA. Age features of uterine motility in infertile women with adenomyosis, uterine fibroids and their combination. Health of woman. 2016;(3):149–152. (In Russ.)

[70] Гладчук И.З., Рожковская Н.Н., Гарбузенко Н.Д., Стамова Н.А. Возрастные особенности маточной перистальтики у бесплодных женщин с аденомиозом, миомой матки и их сочетанием // Здоровье женщины. 2016. № 3 (109). C. 149–152.

[71] Chen B, Wen Y, Yu XY, Polan ML. Relaxin increases elastase activity and protease inhibitors in smooth muscle cells from the myometrium compared with cells from leiomyomas. Fertil Steril. 2009;91(4 Suppl):1351–1354. DOI: 10.1016/j.fertnstert.2008.03.043

[72] Chen B., Wen Y., Yu X.Y., Polan M.L. Relaxin increases elastase activity and protease inhibitors in smooth muscle cells from the myometrium compared with cells from leiomyomas // Fertil. Steril. 2009. Vol. 91. No. 4 (Suppl). P. 1351–1354. DOI: 10.1016/j.fertnstert.2008.03.043

[73] Britten JL, Malik M, Lewis TD, Catherino WH. Ulipristal acetate mediates decreased proteoglycan expression through regulation of nuclear factor of activated T-Cells (NFAT5). Reprod Sci. 2019;26(2):184–197. DOI: 10.1177/1933719118816836

[74] Britten J.L., Malik M., Lewis T.D., Catherino W.H. Ulipristal acetate mediates decreased proteoglycan expression through regulation of nuclear factor of activated T-Cells (NFAT5) // Reprod. Sci. 2019. Vol. 26. No. 2. Р. 184–197. DOI: 10.1177/1933719118816836

[75] Shapovalova AI. Uterine fibroid and reproduction. Journal of obstetrics and women’s diseases. 2019;68(1):93–101. (In Russ.). DOI: 10.17816/JOWD68193-101

[76] Шаповалова А.И. Лейомиома матки и репродукция // Журнал акушерства и женских болезней. 2019. Т. 68. № 1. C. 93–101. DOI: 10.17816/JOWD68193-101

[77] Streuli I, Santulli P, Chouzenoux S, et al. Activation of the MAPK/ERK cell-signaling pathway in uterine smooth muscle cells of women with adenomyosis. Reprod Sci. 2015;22(12):1549–1560. DOI: 10.1177/1933719115589410

[78] Streuli I., Santulli P., Chouzenoux S. et al. Activation of the MAPK/ERK cell-signaling pathway in uterine smooth muscle cells of women with adenomyosis // Reprod. Sci. 2015. Vol. 22. No. 12. P. 1549–1560. DOI: 10.1177/1933719115589410

[79] Lisiecki M, Paszkowski M, Woźniak S. Fertility impairment associated with uterine fibroids – a review of literature. Prz Menopauzalny. 2017;16(4):137–140. DOI: 10.5114/pm.2017.72759

[80] Lisiecki M., Paszkowski M., Woźniak S. Fertility impairment associated with uterine fibroids – a review of literature // Prz. Menopauzalny. 2017. Vol. 16. No. 4. P. 137–140. DOI: 10.5114/pm.2017.72759

[81] Yoshino O, Hayashi T, Osuga Y, et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod. 2010;25(10):2475–2479. DOI: 10.1093/humrep/deq222

[82] Yoshino O., Hayashi T., Osuga Y. et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids // Hum. Reprod. 2010. Vol. 25. No. 10. P. 2475–2479. DOI: 10.1093/humrep/deq222

[83] Tskhay VB, Grigoryan ES, Kostareva OV, Badmaeva SZ. Uterine fibroids and infertility: etiology, pathogenesis and modern treatment principles (literature review). Siberian edical Review. 2019;(4):25–33. (In Russ.). DOI: 10.20333/2500136-2019-4-25-33

[84] Цхай В.Б., Григорян Э.С., Костарева О.В., Бадмаева С.Ж. Миома матки и бесплодие: этиология, патогенез, современные принципы лечения (обзор литературы) // Сибирское медицинское обозрение. 2019. Т. 4 (118). С. 25–33. DOI: 10.20333/2500136-2019-4-25-33

[85] Takahashi N, Yoshino O, Hiraike O, et al. The assessment of myometrium perfusion in patients with uterine fibroid by arterial spin labeling MRI. Springerplus. 2016;5(1):1907. DOI: 10.1186/s40064-016-3596-0

[86] Takahashi N., Yoshino O., Hiraike O. et al. The assessment of myometrium perfusion in patients with uterine fibroid by arterial spin labeling MRI // Springerplus. 2016. Vol. 5. No. 1. P. 1907. DOI: 10.1186/s40064-016-3596-0

[87] Ng EH, Ho PC. Doppler ultrasound examination of uterine arteries on the day of oocyte retrieval in patients with uterine fibroids undergoing IVF. Hum Reprod. 2002;17(3):765–770. DOI: 10.1093/humrep/17.3.765

[88] Ng E.H., Ho P.C. Doppler ultrasound examination of uterine arteries on the day of oocyte retrieval in patients with uterine fibroids undergoing IVF // Hum. Reprod. 2002. Vol. 17. No. 3. Р. 765–770. DOI: 10.1093/humrep/17.3.765

[89] Yarmolinskaya MI, Bezhenar VF, Dolinsky AK, et al. Efficiency of differentiation hormone therapy after laparoscopic myomectomy. Obstetrics and Gynecology. 2013;(8):108–112. (In Russ.)

[90] Ярмолинская М.И., Беженарь В.Ф., Долинский А.К. и др. Эффективность дифференцированной гормональной терапии после лапароскопической миомэктомии // Акушерство и гинекология. 2013. № 8. С. 108–112.

[91] Vysotskiy MM, Kuranov II, Nevzorov OB. Indicators of the reproductive function after endoscopic surgical treatment of uterine myomas. Akuserstvo, Ginekologia i Reprodukcia. 2019;13(4):297–304. (In Russ.). DOI: 10.17749/2313-7347.2019.13.4.297-304

[92] Высоцкий М.М., Куранов И.И., Невзоров О.Б. Показатели репродуктивного здоровья после эндоскопических видов хирургического лечения миомы матки // Акушерство, гинекология и репродукция. 2019. Т. 13. № 4. С. 297–304. DOI: 10.17749/2313-7347.2019.13.4.297-304

[93] Kuznetsova IV, Evsyukova LV. Uterine fibroids and fertility. Gynecology. 2016;18(3):23–29. (In Russ.)

[94] Кузнецова И.В., Евсюкова Л.В. Миома матки и фертильность // Гинекология. 2016. Т. 18. № 3. С. 23–29.

[95] Barinov SV, Shamina IV, Tirskaya Yu I, et al. Management of pregnant women with large uterine fibroids. Fundamental and clinical medicine. 2018;(2):34–41. (In Russ.). DOI: 10.23946/2500-0764-2018-3-2-34-41

[96] Баринов С.В., Шамина И.В., Тирская Ю.И. и др. Опыт ведения беременных с миомой матки больших размеров // Фундаментальная и клиническая медицина. 2018. № 2. С. 34–41. DOI: 10.23946/2500-0764-2018-3-2-34-41

[97] Petrov YuA, Ozdoeva IM-B, Sultygova LA., Prokoptsova AA. Pregnancy and childbirth with uterine fibroids. International Journal of Applied and Fundamental Research. 2019;(3):76–80. (In Russ.)

[98] Петров Ю.А., Оздоева И.М.-Б., Султыгова Л.А., Прокопцова А.А. Беременность и роды при фибромиоме матки // Международный журнал прикладных и фундаментальных исследований. 2019. № 3. С. 76–80.

[99] Karim T, Patil K, Panchal A, Basu Ch. Presentation and management of giant fibroid uterus in an adolescent girl. Open Access Surg. 2010;(3):13–15. DOI: 10.2147/OAS.S9371

[100] Karim T., Patil K., Panchal A., Basu Ch. Presentation and management of giant fibroid uterus in an adolescent girl // Open Access Surg. 2010. Vol. 3. P. 13–15. DOI: 10.2147/OAS.S9371

[101] Gabidullina RI, Mingazetdinov MA, Druzhkowa EB, Sirmatova LI. Experience of pyomyoma treatment. Gynecology. 2020;22(5):81–83. (In Russ.). DOI: 10.26442/20795696.2020.5.200399

[102] Габидуллина Р.В., Мингазетдинов М.А., Дружкова Е.Б., Сирматова Л.И. Опыт лечения пиомиомы матки // Гинекология. 2020. Т. 22. № 5. C. 81–83. DOI: 10.26442/20795696.2020.5.200399

[103] Luyckx M, Squifflet JL, Jadoul P, et al. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids. Fertil Steril. 2014;102(5):1404–1409. DOI: 10.1016/j.fertnstert.2014.07.1253

[104] Luyckx M., Squifflet J.L., Jadoul P. et al. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids // Fertil. Steril. 2014. Vol. 102. No. 5. P. 1404–1409. DOI: 10.1016/j.fertnstert.2014.07.1253

[105] Egamberdieva LD, Tukhvatshina NI, Mukhametzyanova LM. Features of the course of pregnancy and childbirth in patients with uterine myoma. Practical medicine. 2017;(8):190–193. (In Russ.)

[106] Эгамбердиева Л.Д., Тухватшина Н.И., Мухаметзянова Л.М. Особенности течения беременности и родов у пациенток с миомой матки // Практическая медицина. 2017. № 8 (109). С. 190–193.

[107] Lebedeva YA, Kovalenko II, Molchanov OL, et al. The role of vitamin D deficiency in the risk for uterine fibroids relapse after laparoscopic conservative myomectomy in women of reproductive age. Gynecology. 2019;21(5):20–24. (In Russ.). DOI: 10.26442/20795696.2019.5.190697

[108] Лебедева Я.А., Коваленко И.И., Молчанов О.Л. и др. Роль дефицита витамина D как риска рецидива миомы матки после лапароскопической консервативной миомэктомии у женщин репродуктивного возраста // Гинекология. 2019. Т. 21. № 5. С. 20–24. DOI: 10.26442/20795696.2019.5.190697

[109] Fominova GV, Lyalichkina NA, Kosenko YY, et al. During the gestational process and delivery in patients with uterine myoma. Modern problems of science and education. 2018;(4):138. (In Russ.)

[110] Фоминова Г.В., Ляличкина Н.А., Косенко Ю.Ю. и др. Течение гестационного процесса и родоразрешение пациенток с миомой матки // Современные проблемы науки и образования. 2018. № 4. С. 138.

RIGHTS & PERMISSIONS

Eсо-Vector